The U.S. Federal Trade Commission has reached a settlement with Vyera Pharmaceuticals, Martin Shkreli's former company, over allegations it sought to block generic versions of its drug Daraprim. Litigation against Shkreli will continue https://t.co/Ge5kgaxXHc pic.twitter.com/Gpe0ncDNHu— Reuters (@Reuters) December 7, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


